Therabron Therapeutics Receives from FDA Rare Pediatric Disease Designation for Lead Phase 2 Program in Preterm Infants

ROCKVILLE, MD, June 2, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that the U.S. Food and Drug […]

By |June 2nd, 2016|Recent News|

Therabron Therapeutics to Present at Upcoming Industry and Investor Conferences

ROCKVILLE, MD, June 1, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that President and Chief Executive Officer, […]

By |June 1st, 2016|Recent News|